diosgenin has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binesh, A; Devaraj, H; Devaraj, SN | 1 |
| Benghuzzi, H; Cason, Z; Higdon, K; Hughes, J; Puckett, A; Scott, A; Tsao, A; Tucci, M | 1 |
2 other study(ies) available for diosgenin and Disease Exacerbation
| Article | Year |
|---|---|
Inhibition of nuclear translocation of notch intracellular domain (NICD) by diosgenin prevented atherosclerotic disease progression.
Topics: Active Transport, Cell Nucleus; Animals; Aorta; Atherosclerosis; Cell Differentiation; Cell Line; Cell Nucleus; Diosgenin; Disease Progression; Macrophages; Male; Protein Domains; Rats; Rats, Wistar; Receptors, Notch; RNA, Messenger; Signal Transduction | 2018 |
The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems.
Topics: Animals; Bone Resorption; Calcium Phosphates; Dehydroepiandrosterone; Diosgenin; Disease Progression; Drug Delivery Systems; Drug Implants; Estradiol; Female; Lysine; Osteoporosis; Ovariectomy; Phosphates; Rats; Rats, Sprague-Dawley | 2001 |